Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,7.40207936963181e-12,7.547174143919171,193.42848960200283,"['RPL41', 'RPL34', 'RPS3A', 'RPL23A', 'RPL10A', 'RPS4Y1', 'RPL9', 'RPS26', 'RPL7A', 'RPS28', 'RPS15A', 'RPS27', 'RPS19', 'RPS18', 'RPL27A', 'RPL37A', 'RPL26', 'FAU', 'RPS27A', 'RPS10', 'RPL17', 'RPS21', 'RPS12']",3.0496567002883057e-09,0,0,23
2,Vitamin D Receptor Pathway WP2877,6.730620058846962e-06,5.285435168738899,62.94341911750437,"['CDKN1A', 'SERPINB1', 'GADD45A', 'HILPDA', 'TNFRSF11B', 'ATP2C2', 'CYP3A5', 'CEACAM1', 'BCL6', 'S100A6', 'CD9', 'PRKCQ', 'JUNB']",0.0013865077321224741,0,0,13
3,Genotoxicity pathway WP4286,1.6588997311319067e-05,6.533682890687336,71.91475067792132,"['ARRDC4', 'ACTA2', 'ITPKC', 'BTG2', 'CDKN1A', 'RPS27', 'CEBPD', 'GADD45A', 'PCDH8', 'TRIM22']",0.002278222297421152,0,0,10
4,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,3.9728787974398435e-05,5.784957092377587,58.62148375293351,"['CDKN1A', 'CEBPB', 'MAOB', 'CEBPD', 'WNT7B', 'HMGA2', 'TNFRSF11B', 'HES1', 'JUNB', 'HES5']",0.004092065161363039,0,0,10
5,Spinal Cord Injury WP2431,9.039769643669894e-05,4.2695035460992905,39.75459324267384,"['LGALS3', 'EGR1', 'ZFP36', 'BTG2', 'VCAN', 'IL1R1', 'COL4A1', 'GADD45A', 'PLA2G5', 'FOS', 'ICAM1', 'GFAP']",0.006222026871354314,0,0,12
6,Complement and Coagulation Cascades WP558,9.061204181583951e-05,10.989473684210527,102.30016919279088,"['C3', 'CPB2', 'C1R', 'PROS1', 'SERPING1', 'F3']",0.006222026871354314,0,0,6
7,Complement system WP2806,0.00042308211098348296,6.1361656605792,47.665392956229944,"['C3', 'RPS19', 'C1R', 'PROS1', 'SERPING1', 'LAMB1', 'ICAM1']",0.024901404246456423,0,0,7
8,Adipogenesis WP236,0.0005408328306282379,3.423434222355409,25.752442715611096,"['SOCS3', 'CDKN1A', 'CEBPB', 'KLF6', 'GADD45B', 'CEBPD', 'GADD45A', 'NAMPT', 'PNPLA3', 'ID3', 'FAS', 'IRS2']",0.027852890777354256,0,0,12
9,Oncostatin M Signaling Pathway WP2374,0.0008132683951556388,4.130952380952381,29.389451578849876,"['SOCS3', 'EGR1', 'CEBPB', 'SHC1', 'FOS', 'OSMR', 'JUNB', 'LDLR', 'VEGFA']",0.0347914034004938,0,0,9
10,IL-4 signaling pathway WP395,0.000844451538846937,4.611670020120724,32.63597342508394,"['SOCS3', 'CEBPB', 'NFIL3', 'SHC1', 'INPP5D', 'PIK3CD', 'IRS2', 'FOS']",0.0347914034004938,0,0,8
11,Globo Sphingolipid Metabolism WP1424,0.000931941602703346,8.379305312317571,58.47280688187846,"['ST6GAL1', 'ST6GAL2', 'ST8SIA1', 'FUT2', 'A4GALT']",0.03490544911943441,0,0,5
12,Differentiation Pathway WP2848,0.001240203092195304,7.734069783106561,51.76010833778993,"['NT5E', 'EGF', 'HGF', 'WNT7B', 'VEGFA']",0.041011445765337586,0,0,5
13,Differentiation of white and brown adipocyte WP2895,0.0012940504731781277,11.476523476523477,76.3186295318749,"['SMAD1', 'CEBPB', 'SMAD9', 'SLC7A10']",0.041011445765337586,0,0,4
14,Apoptosis Modulation and Signaling WP1772,0.0022692190745662627,3.492979242979243,21.266373731360883,"['IL1R1', 'BAG3', 'TNFRSF10B', 'FAS', 'TNFRSF11B', 'FOS', 'MAP3K14', 'TNFRSF1A', 'HSPA1A']",0.06677987562295001,0,0,9
15,Type II interferon signaling (IFNG) WP619,0.0026158494347276874,6.282289842381786,37.35554079201378,"['SOCS3', 'CIITA', 'GBP1', 'ICAM1', 'PSMB9']",0.07184866447385381,0,0,5
16,"GPCRs, Class A Rhodopsin-like WP455",0.0029658362881838495,4.14695544298563,24.13775322966048,"['P2RY12', 'OXTR', 'EDNRA', 'P2RY14', 'GPR87', 'GPR171', 'ACKR4']",0.07495613562456933,0,0,7
17,Hematopoietic Stem Cell Differentiation WP2849,0.0032542413868292966,5.912228288863707,33.86403808421969,"['HES6', 'CIITA', 'TRIM29', 'FOS', 'RUNX1']",0.07495613562456933,0,0,5
18,Gene regulatory network modelling somitogenesis  WP2854,0.003274782624374388,15.040575916230367,86.0547120533653,"['LFNG', 'HES1', 'TBX6']",0.07495613562456933,0,0,3
19,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.003915602906869229,3.915885569224761,21.704915562663786,"['SOCS3', 'NQO1', 'CDKN1A', 'HSPB1', 'TNFRSF10B', 'YBX3', 'ETS1']",0.08490675777000645,0,0,7
20,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.005054886780480675,12.031413612565444,63.61489422105755,"['CDKN1A', 'FAM20C', 'FGFR3']",0.09917206445514468,0,0,3
21,Galanin receptor pathway WP4970,0.005054886780480675,12.031413612565444,63.61489422105755,"['CDKN1A', 'FOS', 'VEGFA']",0.09917206445514468,0,0,3
22,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.005750998666584552,3.6137172727682394,18.64093325880951,"['IL1R1', 'IRAK2', 'IRF7', 'TAB2', 'IL1RAP', 'FOS', 'MAP3K14']",0.10770052048331069,0,0,7
23,Osteoblast differentiation WP4787,0.007013615565870591,2.8803224993701186,14.286117147579459,"['HES6', 'SMAD1', 'FZD4', 'WNT7B', 'SMAD9', 'PIK3CD', 'WNT7A', 'PRKCQ', 'FGFR3']",0.12254986945300879,0,0,9
24,IL1 and megakaryocytes in obesity WP2865,0.00731562103063618,10.025305410122163,49.3018790110666,"['IL1R1', 'IL18', 'ICAM1']",0.12254986945300879,0,0,3
25,p53 transcriptional gene network WP4963,0.00816390775184341,3.354715875805507,16.129582400513616,"['BTG2', 'CDKN1A', 'GLS2', 'GADD45A', 'FAS', 'PML', 'ICAM1']",0.12254986945300879,0,0,7
26,The influence of laminopathies on Wnt signaling WP4844,0.008196471036075603,4.566549912434326,21.93794131649087,"['CEBPB', 'CEBPD', 'HMGA2', 'HES1', 'HES5']",0.12254986945300879,0,0,5
27,MAPK Signaling Pathway WP382,0.008537674779309046,2.0139137348439675,9.592807992898955,"['PTPRR', 'IL1R1', 'GADD45A', 'DUSP1', 'EGF', 'HSPB1', 'FOS', 'TNFRSF1A', 'MRAS', 'FAS', 'TAB2', 'PTPN7', 'MAP3K6', 'FGFR3', 'MAP3K14', 'HSPA1B', 'HSPA1A']",0.12254986945300879,0,0,17
28,Endochondral Ossification with Skeletal Dysplasias WP4808,0.008626083044022462,3.7707236842105263,17.922116766717526,"['ADAMTS1', 'COL10A1', 'SLC38A2', 'FGFR3', 'DDR2', 'VEGFA']",0.12254986945300879,0,0,6
29,Endochondral Ossification WP474,0.008626083044022462,3.7707236842105263,17.922116766717526,"['ADAMTS1', 'COL10A1', 'SLC38A2', 'FGFR3', 'DDR2', 'VEGFA']",0.12254986945300879,0,0,6
30,Bladder cancer WP2828,0.009595306726865389,4.367623543744765,20.29408060899042,"['CDKN1A', 'EGF', 'DAPK2', 'FGFR3', 'VEGFA']",0.12983411561163344,0,0,5
31,Breast cancer pathway WP4262,0.009926171696788392,2.4131011927664487,11.130623275310818,"['CDKN1A', 'GADD45B', 'SHC1', 'GADD45A', 'EGF', 'WNT7B', 'PIK3CD', 'WNT7A', 'HES1', 'FOS', 'HES5']",0.12983411561163344,0,0,11
32,Hypertrophy Model WP516,0.010084203154301627,8.592370979805535,39.49728309691504,"['IL1R1', 'IL18', 'VEGFA']",0.12983411561163344,0,0,3
33,ESC Pluripotency Pathways WP3931,0.012657370570909677,2.590702947845805,11.320116892879682,"['SMAD1', 'FZD4', 'EGF', 'WNT7B', 'SMAD9', 'PIK3CD', 'WNT7A', 'FOS', 'FGFR3']",0.15147157007425868,0,0,9
34,Cells and molecules involved in local acute inflammatory response  WP4493,0.012789632785274561,20.022648083623693,87.2811332204664,"['C3', 'ICAM1']",0.15147157007425868,0,0,2
35,Aryl Hydrocarbon Receptor Netpath WP2586,0.01286773046747343,4.017513134851138,17.488365710323478,"['NQO1', 'CDKN1A', 'KLF6', 'PSRC1', 'VEGFA']",0.15147157007425868,0,0,5
36,Vitamin B12 metabolism WP1533,0.013502893105688887,5.017045454545454,21.597634709232484,"['SERPINA3', 'SOD2', 'LDLR', 'ICAM1']",0.15453310998732836,0,0,4
37,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.014755843563671803,3.8626566078404956,16.28540871634845,"['CDKN1A', 'FAS', 'FOS', 'JUNB', 'TNFRSF1A']",0.16430831211439953,0,0,5
38,IL-18 signaling pathway WP4754,0.01522220064446261,1.9690603514132925,8.240518255913956,"['BTG2', 'CEBPB', 'RGS16', 'IL18', 'HSPB1', 'TNFRSF11B', 'FOS', 'ICAM1', 'VEGFA', 'TNFRSF1A', 'ACTA2', 'SOCS3', 'TMSB4X', 'FAS', 'PTPN7']",0.16504070172417357,0,0,15
39,Oxidative Stress WP408,0.01606455612039291,4.72151378033731,19.505234046728837,"['NQO1', 'FOS', 'SOD2', 'JUNB']",0.1697076185026123,0,0,4
40,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.01891129856307447,4.458818958818958,17.69257458035061,"['ACAP1', 'IL18', 'ERBIN', 'NOD1']",0.19438713108382893,0,0,4
41,Endometrial cancer WP4155,0.01981616384835149,2.760536200420414,10.824772778445466,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A', 'PIK3CD', 'FOS', 'FGFR3']",0.19438713108382893,0,0,7
42,Neural Crest Differentiation WP2064,0.01981616384835149,2.760536200420414,10.824772778445466,"['SMAD1', 'HES1', 'TBX6', 'ETS1', 'FGFR3', 'HES5', 'GFAP']",0.19438713108382893,0,0,7
43,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.020645698960153277,13.347270615563298,51.79072363611554,"['SMAD1', 'SMAD9']",0.1978146039903058,0,0,2
44,Transcription factor regulation in adipogenesis WP3599,0.021604028183018965,6.013089005235602,23.059447655736218,"['CEBPB', 'CEBPD', 'IRS2']",0.20229226389554122,0,0,3
45,Signal transduction through IL1R WP4496,0.025490333841261273,4.0122377622377625,14.722729784544667,"['IRAK2', 'IL1R1', 'IL1RAP', 'MAP3K14']",0.22316333768953442,0,0,4
46,DNA damage response WP707,0.025733404011205892,2.870426065162907,10.50565997863099,"['CDKN1A', 'GADD45B', 'GADD45A', 'TNFRSF10B', 'FAS', 'PML']",0.22316333768953442,0,0,6
47,Nuclear Receptors Meta-Pathway WP2882,0.026525770901860698,1.8247857741124927,6.623312757791707,"['EGR1', 'NQO1', 'GADD45B', 'HGF', 'IRS2', 'SLC5A3', 'SLC39A14', 'CYP3A5', 'CYP3A7', 'SPINK13', 'HES1', 'SPRY1', 'ANGPTL4', 'JUNB', 'HSPA1A']",0.22316333768953442,0,0,15
48,NAD+ metabolism WP3644,0.026541270744629093,5.465968586387435,19.836297189462105,"['NT5E', 'NAMPT', 'CD38']",0.22316333768953442,0,0,3
49,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.026541270744629093,5.465968586387435,19.836297189462105,"['ICAM1', 'VEGFA', 'TNFRSF1A']",0.22316333768953442,0,0,3
50,Complement Activation WP545,0.029998633400000002,10.009581881533101,35.09963437576666,"['C3', 'C1R']",0.23319692378867926,0,0,2
51,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.029998633400000002,10.009581881533101,35.09963437576666,"['SOCS3', 'CHI3L1']",0.23319692378867926,0,0,2
52,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.029998633400000002,10.009581881533101,35.09963437576666,"['LFNG', 'TBX6']",0.23319692378867926,0,0,2
53,Transcriptional cascade regulating adipogenesis WP4211,0.029998633400000002,10.009581881533101,35.09963437576666,"['CEBPB', 'CEBPD']",0.23319692378867926,0,0,2
54,miRNA regulation of DNA damage response WP1530,0.030785668195457194,2.7394736842105263,9.535302532280944,"['CDKN1A', 'GADD45B', 'GADD45A', 'TNFRSF10B', 'FAS', 'PML']",0.23488324623200674,0,0,6
55,IL-3 signaling pathway WP286,0.03323587738097373,3.0414477524810275,10.35346937220121,"['SHC1', 'INPP5D', 'PIK3CD', 'ENPP3', 'FOS']",0.24896693601747594,0,0,5
56,DNA damage response (only ATM dependent) WP710,0.034237746729536236,2.266217020432454,7.647182854629857,"['CDKN1A', 'BCL6', 'SHC1', 'WNT7B', 'PIK3CD', 'WNT7A', 'SOD2', 'LDLR']",0.25189199379587374,0,0,8
57,IL17 signaling pathway WP2112,0.037650373947249856,3.4879902705989663,11.43855851862753,"['CEBPB', 'CEBPD', 'MAP3K14', 'IL17RB']",0.2703373797314883,0,0,4
58,Apoptosis Modulation by HSP70 WP384,0.03805720394278233,4.624244865082561,15.115106806758295,"['FAS', 'TNFRSF1A', 'HSPA1A']",0.2703373797314883,0,0,3
59,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.04068819625839872,8.006968641114982,25.636850289854166,"['HES1', 'VEGFA']",0.2841277433637335,0,0,2
60,Folate Metabolism WP176,0.04232622455237463,3.3423659673659674,10.569725733461839,"['SERPINA3', 'SOD2', 'LDLR', 'ICAM1']",0.2906400752596391,0,0,4
61,Sleep regulation WP3591,0.044620590979388315,4.293567688855647,13.351105678539975,"['OXTR', 'IL18', 'FOS']",0.30137186038537683,0,0,3
62,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.04874045071115993,2.232376488966999,6.744558501116201,"['MRAS', 'SHC1', 'EGF', 'HGF', 'PIK3CD', 'FGFR3', 'VEGFA']",0.3233420215752691,0,0,7
63,Ovarian infertility WP34,0.05170550098809206,4.006980802792321,11.869442876058706,"['EGR1', 'CEBPB', 'SYNE2']",0.3233420215752691,0,0,3
64,Prostaglandin Synthesis and Regulation WP98,0.05170550098809206,4.006980802792321,11.869442876058706,"['HSD11B1', 'EDNRA', 'S100A6']",0.3233420215752691,0,0,3
65,Development and heterogeneity of the ILC family WP3893,0.052565986783179475,6.671893147502904,19.65330228815287,"['NFIL3', 'IL18']",0.3233420215752691,0,0,2
66,Inflammatory Response Pathway WP453,0.052565986783179475,6.671893147502904,19.65330228815287,"['LAMB1', 'TNFRSF1A']",0.3233420215752691,0,0,2
67,Type 2 papillary renal cell carcinoma WP4241,0.052613941617993584,3.0847229693383538,9.083812443318806,"['CDKN1A', 'EGLN3', 'COL21A1', 'VEGFA']",0.3233420215752691,0,0,4
68,Melanoma WP4685,0.05336712977455898,2.3620227038183694,6.922049892260494,"['CDKN1A', 'GADD45B', 'GADD45A', 'PIK3CD', 'FOS', 'ETS1']",0.3233420215752691,0,0,6
69,VEGFA-VEGFR2 Signaling Pathway WP3888,0.056962655500278896,1.457370413892153,4.175890003833675,"['EGR1', 'SHC1', 'HSPB1', 'NRARP', 'PLA2G5', 'SHB', 'RPL10A', 'BMX', 'SOD2', 'F3', 'ETS1', 'NDRG1', 'APOLD1', 'RAB11A', 'ICAM1', 'VEGFA', 'ADAMTS1', 'TMSB4X', 'TXNIP', 'FAS', 'MYH9', 'RPL26', 'TMSB10', 'HSPA1A']",0.3401248415378972,0,0,24
70,7-oxo-C and 7beta-HC pathways WP5064,0.05929710780110798,3.756217277486911,10.612045319042993,"['HSD11B1', 'DBP', 'DHCR7']",0.34409025935290827,0,0,3
71,TYROBP causal network in microglia WP3945,0.05929710780110798,3.756217277486911,10.612045319042993,"['C3', 'IL18', 'IL13RA1']",0.34409025935290827,0,0,3
72,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.06413708683268024,2.863886113886114,7.866329078581385,"['IFITM3', 'IFITM2', 'FOS', 'JUNB']",0.36464606465592475,0,0,4
73,Dopamine metabolism WP2436,0.06549468151586998,5.7182677949228475,15.58677623167515,"['NQO1', 'MAOB']",0.36464606465592475,0,0,2
74,Peptide GPCRs WP24,0.06549468151586998,5.7182677949228475,15.58677623167515,"['OXTR', 'EDNRA']",0.36464606465592475,0,0,2
75,Unfolded protein response WP4925,0.06737844855917399,3.5349553433939023,9.535294827044828,"['XBP1', 'TNFRSF10B', 'TXNIP']",0.37013227741839577,0,0,3
76,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.07593077229907721,3.338278068644561,8.60585801291311,"['HSPB1', 'NDRG1', 'RAB11A']",0.3846011179832612,0,0,3
77,miRNAs involvement in the immune response in sepsis WP4329,0.07593077229907721,3.338278068644561,8.60585801291311,"['IRF7', 'TAB2', 'ICAM1']",0.3846011179832612,0,0,3
78,TLR4 Signaling and Tolerance WP3851,0.07593077229907721,3.338278068644561,8.60585801291311,"['INPP5D', 'IRF7', 'TAB2']",0.3846011179832612,0,0,3
79,Tryptophan metabolism WP465,0.07593077229907721,3.338278068644561,8.60585801291311,"['WARS', 'MAOB', 'HAAO']",0.3846011179832612,0,0,3
80,Wnt signaling in kidney disease WP4150,0.07593077229907721,3.338278068644561,8.60585801291311,"['FZD4', 'WNT7B', 'WNT7A']",0.3846011179832612,0,0,3
81,Eicosanoid Synthesis WP167,0.07934731803052719,5.003048780487805,12.677328526870625,"['PNPLA3', 'PLA2G5']",0.3846011179832612,0,0,2
82,ID signaling pathway WP53,0.07934731803052719,5.003048780487805,12.677328526870625,"['ID3', 'ELK3']",0.3846011179832612,0,0,2
83,Kynurenine Pathway and links to Cellular Senescence WP5044,0.07934731803052719,5.003048780487805,12.677328526870625,"['CDKN1A', 'HAAO']",0.3846011179832612,0,0,2
84,NOTCH1 regulation of endothelial cell calcification WP3413,0.07934731803052719,5.003048780487805,12.677328526870625,"['FGFR3', 'VEGFA']",0.3846011179832612,0,0,2
85,Overview of nanoparticle effects WP3287,0.07934731803052719,5.003048780487805,12.677328526870625,"['COL4A1', 'PIK3CD']",0.3846011179832612,0,0,2
86,Circadian rhythm related genes WP3594,0.08193367101031947,1.718160128054121,4.298570753675346,"['EGR1', 'DBP', 'NFIL3', 'NOCT', 'NAMPT', 'ID3', 'FAS', 'CARTPT', 'RPS27A', 'PML']",0.38880831388220066,0,0,10
87,IL-1 signaling pathway WP195,0.08294102990295964,2.2788966725043784,5.673599055327798,"['IL1R1', 'IRAK2', 'TAB2', 'IL1RAP', 'MAP3K14']",0.38880831388220066,0,0,5
88,Aryl Hydrocarbon Receptor Pathway WP2873,0.08493385497426714,3.162303664921466,7.797869273978666,"['NQO1', 'HES1', 'JUNB']",0.38880831388220066,0,0,3
89,Lung fibrosis WP3624,0.08493385497426714,3.162303664921466,7.797869273978666,"['CEBPB', 'EGF', 'HGF']",0.38880831388220066,0,0,3
90,Vitamin A and carotenoid metabolism WP716,0.08493385497426714,3.162303664921466,7.797869273978666,"['RBP2', 'RBP1', 'BCO1']",0.38880831388220066,0,0,3
91,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.09316184019573397,19.989565217391306,47.44357553059811,['FAS'],0.39672355964570966,0,0,1
92,EV release from cardiac cells and their functional effects WP3297,0.09316184019573397,19.989565217391306,47.44357553059811,['RGS16'],0.39672355964570966,0,0,1
93,let-7 inhibition of ES cell reprogramming WP3299,0.09316184019573397,19.989565217391306,47.44357553059811,['EGR1'],0.39672355964570966,0,0,1
94,GDNF/RET signaling axis WP4830,0.09400662156149395,4.446767324816105,10.513892448807857,"['IFT27', 'SPRY1']",0.39672355964570966,0,0,2
95,Leptin Insulin Overlap WP3935,0.09400662156149395,4.446767324816105,10.513892448807857,"['SOCS3', 'IRS2']",0.39672355964570966,0,0,2
96,TP53 network WP1742,0.09400662156149395,4.446767324816105,10.513892448807857,"['CDKN1A', 'GADD45A']",0.39672355964570966,0,0,2
97,Tryptophan catabolism leading to NAD+ production WP4210,0.09400662156149395,4.446767324816105,10.513892448807857,"['HAAO', 'NAMPT']",0.39672355964570966,0,0,2
98,Oxidation by Cytochrome P450 WP43,0.09436628360504745,3.0039267015706805,7.090983564051249,"['CYP39A1', 'CYP3A5', 'CYP3A7']",0.39672355964570966,0,0,3
99,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.09579862160533566,1.7848200312989044,4.18630784567135,"['EGR1', 'CEBPB', 'CAV3', 'CHRNA4', 'PAH', 'HES1', 'HES5', 'VEGFA']",0.3986770919333161,0,0,8
100,TGF-beta Receptor Signaling WP560,0.09812324518352965,2.428904428904429,5.6387768949959085,"['SMAD1', 'EGF', 'SMAD9', 'FOS']",0.4042677701561422,0,0,4
101,Oxysterols derived from cholesterol WP4545,0.10420571192153026,2.8606332585390177,6.469002679456252,"['CYP39A1', 'DBP', 'DHCR7']",0.4209093461928477,0,0,3
102,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.10420571192153026,2.8606332585390177,6.469002679456252,"['ACTA2', 'PRKCQ', 'TNFRSF1A']",0.4209093461928477,0,0,3
103,Glycogen Synthesis and Degradation WP500,0.10575705761446355,2.3572603866721513,5.295846465399803,"['HKDC1', 'PYGM', 'PYGL', 'GYG2']",0.4230282304578542,0,0,4
104,Cysteine and methionine catabolism WP4504,0.10936437212920089,4.001742160278746,8.856135955356587,"['BHMT', 'SQOR']",0.42912496492600727,0,0,2
105,Pyrimidine metabolism and related diseases WP4225,0.10936437212920089,4.001742160278746,8.856135955356587,"['NT5C', 'GLS2']",0.42912496492600727,0,0,2
106,Integrated breast cancer pathway WP1984,0.11076727514187379,1.6580748507354013,3.6483017204017614,"['BARD1', 'SMAD1', 'ITPKC', 'RASGEF1A', 'GADD45A', 'FAU', 'PML', 'FOSL2', 'VEGFA']",0.430529409042,0,0,9
107,Gastrin signaling pathway WP4659,0.11587788853578111,1.7777580031589955,3.8314566300444017,"['EGR1', 'CDKN1A', 'SHC1', 'PRKCQ', 'FOS', 'CD44', 'VEGFA']",0.43985784677708617,0,0,7
108,Small cell lung cancer WP4658,0.1163701584919961,1.8800986842105263,4.044053063845274,"['CDKN1A', 'GADD45B', 'COL4A1', 'GADD45A', 'PIK3CD', 'LAMB1']",0.43985784677708617,0,0,6
109,Wnt signaling pathway and pluripotency WP399,0.1163701584919961,1.8800986842105263,4.044053063845274,"['FZD4', 'WNT7B', 'WNT7A', 'PRKCQ', 'LDLR', 'CD44']",0.43985784677708617,0,0,6
110,Oxidative Damage WP3941,0.12501286908642667,2.611427270657865,5.430041510054256,"['CDKN1A', 'C1R', 'GADD45A']",0.4533367246809853,0,0,3
111,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.12532080989575495,3.637630662020906,7.554916368328857,"['EGF', 'HSPB1']",0.4533367246809853,0,0,2
112,Phytochemical activity on NRF2 transcriptional activation WP3,0.12532080989575495,3.637630662020906,7.554916368328857,"['NQO1', 'CEBPB']",0.4533367246809853,0,0,2
113,Insulin Signaling WP481,0.12778331642262705,1.5566877585120662,3.2027594228450784,"['SOCS3', 'EGR1', 'XBP1', 'SHC1', 'PIK3CD', 'IRS2', 'PRKCQ', 'FOS', 'MAP3K6', 'MAP3K14']",0.4533367246809853,0,0,10
114,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.1301838722141972,2.1655641655641658,4.4151683026706925,"['SMAD1', 'EGF', 'SMAD9', 'FOS']",0.4533367246809853,0,0,4
115,TGF-beta Signaling Pathway WP366,0.13344634996704033,1.6379706812302386,3.298964276758943,"['CDKN1A', 'KLF6', 'SHC1', 'LIMK2', 'FOS', 'ETS1', 'JUNB', 'PML']",0.4533367246809853,0,0,8
116,Pancreatic adenocarcinoma pathway WP4263,0.13464579239310256,1.7954438334642577,3.6000582709916245,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A', 'PIK3CD', 'VEGFA']",0.4533367246809853,0,0,6
117,Senescence and Autophagy in Cancer WP615,0.13464579239310256,1.7954438334642577,3.6000582709916245,"['CDKN1A', 'CEBPB', 'IFI16', 'IRF7', 'COL10A1', 'CD44']",0.4533367246809853,0,0,6
118,Benzene metabolism WP3891,0.1364411501467043,9.99391304347826,19.906494541054258,['NQO1'],0.4533367246809853,0,0,1
119,Composition of Lipid Particles WP3601,0.1364411501467043,9.99391304347826,19.906494541054258,['LDLR'],0.4533367246809853,0,0,1
120,Hypothetical Craniofacial Development Pathway WP3655,0.1364411501467043,9.99391304347826,19.906494541054258,['ARHGAP29'],0.4533367246809853,0,0,1
121,Macrophage markers WP4146,0.1364411501467043,9.99391304347826,19.906494541054258,['F3'],0.4533367246809853,0,0,1
122,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.1364411501467043,9.99391304347826,19.906494541054258,['VEGFA'],0.4533367246809853,0,0,1
123,Steroid Biosynthesis WP496,0.1364411501467043,9.99391304347826,19.906494541054258,['HSD17B7'],0.4533367246809853,0,0,1
124,Tamoxifen metabolism WP691,0.1364411501467043,9.99391304347826,19.906494541054258,['CYP3A5'],0.4533367246809853,0,0,1
125,Myometrial relaxation and contraction pathways WP289,0.13861915350761034,1.621283255086072,3.203696258850217,"['RGS4', 'ACTA2', 'RGS17', 'OXTR', 'GRK5', 'RGS16', 'PRKCQ', 'FOS']",0.45386365347630275,0,0,8
126,Exercise-induced Circadian Regulation WP410,0.13880296198547123,2.1083916083916083,4.163440679664513,"['CEBPB', 'RBPMS', 'TAB2', 'ETV6']",0.45386365347630275,0,0,4
127,Allograft Rejection WP2328,0.1471660265909023,2.4020942408376964,4.602878324171237,"['C3', 'FAS', 'VEGFA']",0.47154415431753743,0,0,3
128,Alpha 6 Beta 4 signaling pathway WP244,0.1471660265909023,2.4020942408376964,4.602878324171237,"['SHC1', 'IRS2', 'LAMB1']",0.47154415431753743,0,0,3
129,Glucocorticoid Receptor Pathway WP2880,0.1476436793858309,2.0541509772279003,3.929495259915153,"['GADD45B', 'SPINK13', 'SPRY1', 'ANGPTL4']",0.47154415431753743,0,0,4
130,T-cell receptor (TCR) signaling pathway WP69,0.14962632115976313,1.8552571836284621,3.524273048994183,"['SHC1', 'FAS', 'PRKCQ', 'FOS', 'MAP3K14']",0.4737095085546881,0,0,5
131,RANKL/RANK signaling pathway WP2018,0.15669549270005212,2.0026223776223775,3.7117622359754607,"['TNFRSF11B', 'TAB2', 'FOS', 'ICAM1']",0.4737095085546881,0,0,4
132,Selenium Micronutrient Network WP15,0.15669549270005212,2.0026223776223775,3.7117622359754607,"['SERPINA3', 'SOD2', 'LDLR', 'ICAM1']",0.4737095085546881,0,0,4
133,Cholesterol Biosynthesis Pathway WP197,0.15866968975860912,3.077459126239614,5.665388861929605,"['MSMO1', 'DHCR7']",0.4737095085546881,0,0,2
134,MAPK pathway in congenital thyroid cancer WP4928,0.15866968975860912,3.077459126239614,5.665388861929605,"['SHC1', 'FOS']",0.4737095085546881,0,0,2
135,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.15866968975860912,3.077459126239614,5.665388861929605,"['ACTN1', 'PRKCQ']",0.4737095085546881,0,0,2
136,Pregnane X receptor pathway WP2876,0.15866968975860912,3.077459126239614,5.665388861929605,"['CYP3A5', 'CYP3A7']",0.4737095085546881,0,0,2
137,Purinergic signaling WP4900,0.15866968975860912,3.077459126239614,5.665388861929605,"['P2RY12', 'P2RY14']",0.4737095085546881,0,0,2
138,Statin inhibition of cholesterol production WP430,0.15866968975860912,3.077459126239614,5.665388861929605,"['APOC1', 'LDLR']",0.4737095085546881,0,0,2
139,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.16772839044626123,1.5946836555360282,2.847163079258314,"['CLDN11', 'COL4A1', 'SHC1', 'FZD4', 'WNT7B', 'PIK3CD', 'WNT7A']",0.4945624435770806,0,0,7
140,Non-small cell lung cancer WP4255,0.17304121904074082,1.7571511967308815,3.0824393532185415,"['CDKN1A', 'GADD45B', 'EGF', 'GADD45A', 'PIK3CD']",0.4945624435770806,0,0,5
141,Interferon type I signaling pathways WP585,0.17538914292312968,1.906926406926407,3.319478519536416,"['SOCS3', 'PDCD4', 'PIK3CD', 'IRS2']",0.4945624435770806,0,0,4
142,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.17590005187570723,2.857391737182678,4.965687748730132,"['NQO1', 'FOS']",0.4945624435770806,0,0,2
143,Blood Clotting Cascade WP272,0.17765835351798043,6.662028985507247,11.511272818719686,['F3'],0.4945624435770806,0,0,1
144,Irinotecan pathway WP229,0.17765835351798043,6.662028985507247,11.511272818719686,['CYP3A5'],0.4945624435770806,0,0,1
145,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.17765835351798043,6.662028985507247,11.511272818719686,['CDKN1A'],0.4945624435770806,0,0,1
146,Osteoblast Signaling WP322,0.17765835351798043,6.662028985507247,11.511272818719686,['TNFRSF11B'],0.4945624435770806,0,0,1
147,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.17765835351798043,6.662028985507247,11.511272818719686,['VEGFA'],0.4945624435770806,0,0,1
148,The alternative pathway of fetal androgen synthesis WP4524,0.17765835351798043,6.662028985507247,11.511272818719686,['HSD17B6'],0.4945624435770806,0,0,1
149,Metapathway biotransformation Phase I and II WP702,0.18203767072480045,1.6246088193456614,2.7675887583629577,"['CYP39A1', 'HS3ST3B1', 'CHST9', 'CHST6', 'CYP3A5', 'CYP3A7']",0.5033524854940791,0,0,6
150,Angiogenesis WP1539,0.193403985631392,2.6666666666666665,4.381264234524771,"['SMAD1', 'VEGFA']",0.5136066241730206,0,0,2
151,Monoamine Transport WP727,0.193403985631392,2.6666666666666665,4.381264234524771,"['IL1R1', 'TNFRSF11B']",0.5136066241730206,0,0,2
152,NAD+ biosynthetic pathways WP3645,0.193403985631392,2.6666666666666665,4.381264234524771,"['NAMPT', 'CD38']",0.5136066241730206,0,0,2
153,One-carbon metabolism WP241,0.193403985631392,2.6666666666666665,4.381264234524771,"['BHMT', 'GLRX']",0.5136066241730206,0,0,2
154,Hepatitis C and Hepatocellular Carcinoma WP3646,0.19474463772352973,2.0700487452608773,3.3867366370122407,"['CDKN1A', 'CD44', 'VEGFA']",0.5136066241730206,0,0,3
155,Kit receptor signaling pathway WP304,0.19479576272208066,1.81993006993007,2.977048232846643,"['SHC1', 'INPP5D', 'FOS', 'JUNB']",0.5136066241730206,0,0,4
156,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.19479576272208066,1.81993006993007,2.977048232846643,"['PLCE1', 'PRKCQ', 'ETS1', 'TNFRSF1A']",0.5136066241730206,0,0,4
157,NRF2 pathway WP2884,0.20413838156138098,1.5609022556390977,2.4802068371978563,"['EGR1', 'NQO1', 'HGF', 'SLC5A3', 'SLC39A14', 'HSPA1A']",0.5136066241730206,0,0,6
158,Ferroptosis WP4313,0.20718376525106771,2.00087260034904,3.149671852479568,"['TFRC', 'CP', 'SLC39A14']",0.5136066241730206,0,0,3
159,IL-2 signaling pathway WP49,0.20718376525106771,2.00087260034904,3.149671852479568,"['SOCS3', 'SHC1', 'FOS']",0.5136066241730206,0,0,3
160,Phosphoinositides metabolism WP4971,0.20718376525106771,2.00087260034904,3.149671852479568,"['INPP5D', 'PIK3CD', 'PLCE1']",0.5136066241730206,0,0,3
161,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.21111630058700998,2.499782229965157,3.8880265665685103,"['BCL6', 'H2AFJ']",0.5136066241730206,0,0,2
162,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.21111630058700998,2.499782229965157,3.8880265665685103,"['UGCG', 'GALNT16']",0.5136066241730206,0,0,2
163,Striated Muscle Contraction Pathway WP383,0.21111630058700998,2.499782229965157,3.8880265665685103,"['ACTA2', 'ACTN2']",0.5136066241730206,0,0,2
164,White fat cell differentiation WP4149,0.21111630058700998,2.499782229965157,3.8880265665685103,"['CEBPB', 'CEBPD']",0.5136066241730206,0,0,2
165,Focal Adhesion WP306,0.21333661969248463,1.3985480497108405,2.160594486498253,"['CAV3', 'COL4A1', 'SHC1', 'EGF', 'ACTN1', 'HGF', 'PIK3CD', 'LAMB1', 'VEGFA']",0.5136066241730206,0,0,9
166,Notch Signaling Pathway Netpath WP61,0.21482556776027703,1.7404986318029796,2.6767631338847475,"['HES6', 'CDKN1A', 'HES1', 'HES5']",0.5136066241730206,0,0,4
167,Bile acids synthesis and enterohepatic circulation  WP4389,0.21691153545171257,4.996086956521739,7.635348226407678,['LDLR'],0.5136066241730206,0,0,1
168,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.21691153545171257,4.996086956521739,7.635348226407678,['HSD11B1'],0.5136066241730206,0,0,1
169,Estrogen metabolism WP697,0.21691153545171257,4.996086956521739,7.635348226407678,['NQO1'],0.5136066241730206,0,0,1
170,miR-517 relationship with ARCN1 and USP1 WP3596,0.21691153545171257,4.996086956521739,7.635348226407678,['CDKN1A'],0.5136066241730206,0,0,1
171,NAD Biosynthesis II (from tryptophan) WP2485,0.21691153545171257,4.996086956521739,7.635348226407678,['HAAO'],0.5136066241730206,0,0,1
172,PTF1A related regulatory pathway WP4147,0.21691153545171257,4.996086956521739,7.635348226407678,['HES1'],0.5136066241730206,0,0,1
173,Serotonin Transporter Activity WP1455,0.21691153545171257,4.996086956521739,7.635348226407678,['IL1R1'],0.5136066241730206,0,0,1
174,Vitamin D Metabolism WP1531,0.21691153545171257,4.996086956521739,7.635348226407678,['DHCR7'],0.5136066241730206,0,0,1
175,EGF/EGFR signaling pathway WP437,0.21925954097602715,1.3876678876678876,2.1057848153904843,"['PTPRR', 'PLSCR1', 'SHC1', 'EGF', 'INPP5D', 'LIMK2', 'NEDD4', 'PLCE1', 'FOS']",0.5161996050407038,0,0,9
176,Corticotropin-releasing hormone signaling pathway WP2355,0.22358926431706683,1.5889695049064576,2.3801882127669307,"['IL18', 'PRKCQ', 'FOS', 'JUNB', 'FOSL2']",0.5234021414694974,0,0,5
177,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.22504597163441925,1.7033179586371077,2.540414556094867,"['CDKN1A', 'SHC1', 'FZD4', 'TMSB4X']",0.5238358209795522,0,0,4
178,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.22897738531072714,2.352531256405001,3.467941687008085,"['CEBPB', 'ATP2C2']",0.5270317471956402,0,0,2
179,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.22897738531072714,2.352531256405001,3.467941687008085,"['WIF1', 'PML']",0.5270317471956402,0,0,2
180,IL-6 signaling pathway WP364,0.24544760648414687,1.818499127399651,2.5543943881499254,"['SOCS3', 'SHC1', 'JUNB']",0.5345366316395549,0,0,3
181,Notch Signaling WP268,0.24544760648414687,1.818499127399651,2.5543943881499254,"['LFNG', 'HES1', 'HES5']",0.5345366316395549,0,0,3
182,Apoptosis WP254,0.24584167647949132,1.6335093477950622,2.291923945102622,"['IRF7', 'TNFRSF10B', 'FAS', 'TNFRSF1A']",0.5345366316395549,0,0,4
183,MET in type 1 papillary renal cell carcinoma WP4205,0.24584167647949132,1.6335093477950622,2.291923945102622,"['CDKN1A', 'HGF', 'PIK3CD', 'ETS1']",0.5345366316395549,0,0,4
184,Endothelin Pathways WP2197,0.24693282485103574,2.221641502129307,3.1072743233938094,"['EDNRA', 'CALCRL']",0.5345366316395549,0,0,2
185,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.24693282485103574,2.221641502129307,3.1072743233938094,"['CDKN1A', 'FGFR3']",0.5345366316395549,0,0,2
186,Aspirin and miRNAs WP4707,0.2542941257314387,3.9965217391304346,5.472292169946358,['VEGFA'],0.5345366316395549,0,0,1
187,Biogenic Amine Synthesis WP550,0.2542941257314387,3.9965217391304346,5.472292169946358,['PAH'],0.5345366316395549,0,0,1
188,Caloric restriction and aging WP4191,0.2542941257314387,3.9965217391304346,5.472292169946358,['NAMPT'],0.5345366316395549,0,0,1
189,Farnesoid X receptor pathway WP2879,0.2542941257314387,3.9965217391304346,5.472292169946358,['IRS2'],0.5345366316395549,0,0,1
190,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.2542941257314387,3.9965217391304346,5.472292169946358,['CEBPB'],0.5345366316395549,0,0,1
191,Genes targeted by miRNAs in adipocytes WP1992,0.2542941257314387,3.9965217391304346,5.472292169946358,['TMSB4X'],0.5345366316395549,0,0,1
192,LDLRAD4 and what we know about it WP4904,0.2542941257314387,3.9965217391304346,5.472292169946358,['NEDD4'],0.5345366316395549,0,0,1
193,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.2542941257314387,3.9965217391304346,5.472292169946358,['LDLR'],0.5345366316395549,0,0,1
194,"Phase I biotransformations, non P450 WP136",0.2542941257314387,3.9965217391304346,5.472292169946358,['PON1'],0.5345366316395549,0,0,1
195,Platelet-mediated interactions with vascular and circulating cells WP4462,0.2542941257314387,3.9965217391304346,5.472292169946358,['ICAM1'],0.5345366316395549,0,0,1
196,Urea cycle and related diseases WP4571,0.2542941257314387,3.9965217391304346,5.472292169946358,['GLS2'],0.5345366316395549,0,0,1
197,Cell migration and invasion through p75NTR WP4561,0.2649330419853218,2.1045296167247387,2.7954007199738227,"['EFNA1', 'EFNB3']",0.5403584816730326,0,0,2
198,EPO Receptor Signaling WP581,0.2649330419853218,2.1045296167247387,2.7954007199738227,"['SHC1', 'IRS2']",0.5403584816730326,0,0,2
199,Heart Development WP1591,0.2649330419853218,2.1045296167247387,2.7954007199738227,"['SMAD1', 'VEGFA']",0.5403584816730326,0,0,2
200,NRF2-ARE regulation WP4357,0.2649330419853218,2.1045296167247387,2.7954007199738227,"['NQO1', 'CEBPB']",0.5403584816730326,0,0,2
201,Photodynamic therapy-induced unfolded protein response WP3613,0.2649330419853218,2.1045296167247387,2.7954007199738227,"['XBP1', 'WARS']",0.5403584816730326,0,0,2
202,Pre-implantation embryo WP3527,0.2649330419853218,2.1045296167247387,2.7954007199738227,"['EGR1', 'ZFP36']",0.5403584816730326,0,0,2
203,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.27153450868588785,1.7142857142857142,2.234856075205247,"['PRKCQ', 'FOS', 'MAP3K14']",0.5485411251654305,0,0,3
204,Calcium Regulation in the Cardiac Cell WP536,0.2716077415867666,1.3606565768594194,1.773474856797897,"['RGS4', 'RGS17', 'PLN', 'GRK5', 'RGS16', 'GJA9', 'PRKCQ']",0.5485411251654305,0,0,7
205,Ebola Virus Pathway on Host WP4217,0.27539142597132316,1.3964504283965729,1.8008091646044877,"['SOCS3', 'CAV3', 'ACTN1', 'NEDD4', 'IRF7', 'PIK3CD']",0.5529480953520569,0,0,6
206,Toll-like Receptor Signaling Pathway WP75,0.27775693640705934,1.5388649811726736,1.9712997017120442,"['IRF7', 'PIK3CD', 'TAB2', 'FOS']",0.5529480953520569,0,0,4
207,Male infertility WP4673,0.2778893343602929,1.4500368029645423,1.8568189948456317,"['NQO1', 'BHMT', 'PON1', 'FAS', 'SOD2']",0.5529480953520569,0,0,5
208,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.2829329608270332,1.9991289198606272,2.523990815743117,"['RAB13', 'NDRG1']",0.5529480953520569,0,0,2
209,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.2829329608270332,1.9991289198606272,2.523990815743117,"['P3H2', 'TNFRSF11B']",0.5529480953520569,0,0,2
210,TNF-alpha signaling pathway WP231,0.2872002143961275,1.429196897673255,1.783031313340637,"['OTUD7B', 'TAB2', 'PYGL', 'MAP3K14', 'TNFRSF1A']",0.5529480953520569,0,0,5
211,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.2898951179515638,3.330144927536232,4.123505613069912,['DHCR7'],0.5529480953520569,0,0,1
212,Dual hijack model of Vif in HIV infection WP3300,0.2898951179515638,3.330144927536232,4.123505613069912,['RUNX1'],0.5529480953520569,0,0,1
213,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.2898951179515638,3.330144927536232,4.123505613069912,['BHMT'],0.5529480953520569,0,0,1
214,Nanoparticle triggered regulated necrosis WP2513,0.2898951179515638,3.330144927536232,4.123505613069912,['TNFRSF1A'],0.5529480953520569,0,0,1
215,Osteoclast Signaling WP12,0.2898951179515638,3.330144927536232,4.123505613069912,['TNFRSF11B'],0.5529480953520569,0,0,1
216,Serotonin and anxiety-related events WP3944,0.2898951179515638,3.330144927536232,4.123505613069912,['FOS'],0.5529480953520569,0,0,1
217,Cytosolic DNA-sensing pathway WP4655,0.29789913470437296,1.621338616103014,1.9634415892822172,"['RNF125', 'IL18', 'IRF7']",0.5655965138165975,0,0,3
218,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.309954157140459,1.2169755048159194,1.425480980025812,"['EFNA1', 'CDKN1A', 'COL4A1', 'EGF', 'HGF', 'PIK3CD', 'IRS2', 'LAMB1', 'OSMR', 'FGFR3', 'VEGFA']",0.5825559084225974,0,0,11
219,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.31113981203482244,1.5785340314136125,1.842958862824457,"['MSMO1', 'DHCR7', 'HSD17B7']",0.5825559084225974,0,0,3
220,16p11.2 distal deletion syndrome WP4950,0.3187722332601367,1.8170731707317074,2.077420568257468,"['C3', 'PLN']",0.5825559084225974,0,0,2
221,Neovascularisation processes WP4331,0.3187722332601367,1.8170731707317074,2.077420568257468,"['SMAD1', 'SMAD9']",0.5825559084225974,0,0,2
222,Biomarkers for urea cycle disorders WP4583,0.3237992791960554,2.85416149068323,3.218442299714193,['GLS2'],0.5825559084225974,0,0,1
223,Cancer immunotherapy by CTLA4 blockade WP4582,0.3237992791960554,2.85416149068323,3.218442299714193,['PIK3CD'],0.5825559084225974,0,0,1
224,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.3237992791960554,2.85416149068323,3.218442299714193,['PRKCQ'],0.5825559084225974,0,0,1
225,"GPCRs, Class B Secretin-like WP334",0.3237992791960554,2.85416149068323,3.218442299714193,['CALCRL'],0.5825559084225974,0,0,1
226,Iron metabolism in placenta WP2007,0.3237992791960554,2.85416149068323,3.218442299714193,['TFRC'],0.5825559084225974,0,0,1
227,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.3237992791960554,2.85416149068323,3.218442299714193,['EGF'],0.5825559084225974,0,0,1
228,RAS and bradykinin pathways in COVID-19 WP4969,0.3237992791960554,2.85416149068323,3.218442299714193,['SERPING1'],0.5825559084225974,0,0,1
229,Thiamine metabolic pathways WP4297,0.3237992791960554,2.85416149068323,3.218442299714193,['SLC19A3'],0.5825559084225974,0,0,1
230,Retinoblastoma gene in cancer WP2446,0.33216656027870867,1.4032634032634033,1.5465629055150498,"['BARD1', 'CDKN1A', 'RBP1', 'CDC7']",0.5950114036296869,0,0,4
231,Regulation of toll-like receptor signaling pathway WP1449,0.33446823524987784,1.3333333333333333,1.4602844877423897,"['IRAK2', 'IRF7', 'PIK3CD', 'TAB2', 'FOS']",0.5965407485841977,0,0,5
232,Resistin as a regulator of inflammation WP4481,0.3365411999388235,1.7379184971973944,1.8926535504780482,"['PIK3CD', 'PLCE1']",0.5976507516154969,0,0,2
233,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.3431407198561481,1.3789486375693272,1.4749436698290146,"['CDKN1A', 'GADD45B', 'GADD45A', 'FOS']",0.6041622930800555,0,0,4
234,Prolactin Signaling Pathway WP2037,0.3431407198561481,1.3789486375693272,1.4749436698290146,"['SOCS3', 'SHC1', 'IRS2', 'FOS']",0.6041622930800555,0,0,4
235,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.35416855780981926,1.6653600464576075,1.7286142965940396,"['PIK3CD', 'PRKCQ']",0.6087468395687441,0,0,2
236,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.3560873503302605,2.4971739130434782,2.578529871685037,['PRKCQ'],0.6087468395687441,0,0,1
237,"NAD metabolism, sirtuins and aging WP3630",0.3560873503302605,2.4971739130434782,2.578529871685037,['NAMPT'],0.6087468395687441,0,0,1
238,Neuroinflammation WP4919,0.3560873503302605,2.4971739130434782,2.578529871685037,['FOS'],0.6087468395687441,0,0,1
239,Nicotine Activity on Dopaminergic Neurons WP1602,0.3560873503302605,2.4971739130434782,2.578529871685037,['CHRNA4'],0.6087468395687441,0,0,1
240,NLR Proteins WP288,0.3560873503302605,2.4971739130434782,2.578529871685037,['ERBIN'],0.6087468395687441,0,0,1
241,NO metabolism in cystic fibrosis WP4947,0.3560873503302605,2.4971739130434782,2.578529871685037,['PRMT8'],0.6087468395687441,0,0,1
242,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.36410417040630927,1.4276988282223884,1.4424259269041182,"['WIF1', 'WNT7B', 'WNT7A']",0.6198798273033034,0,0,3
243,Neural Crest Cell Migration during Development WP4564,0.3716273838498624,1.5986062717770035,1.5824021320186266,"['PIK3CD', 'FOS']",0.6300842886672564,0,0,2
244,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.38683623675236073,2.2195169082125603,2.1079946984336297,['VEGFA'],0.6365193726164413,0,0,1
245,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.38683623675236073,2.2195169082125603,2.1079946984336297,['SMAD1'],0.6365193726164413,0,0,1
246,FOXA2 pathway WP5066,0.38683623675236073,2.2195169082125603,2.1079946984336297,['IRS2'],0.6365193726164413,0,0,1
247,Ganglio Sphingolipid Metabolism WP1423,0.38683623675236073,2.2195169082125603,2.1079946984336297,['ST8SIA1'],0.6365193726164413,0,0,1
248,miR-509-3p alteration of YAP1/ECM axis WP3967,0.38683623675236073,2.2195169082125603,2.1079946984336297,['EDNRA'],0.6365193726164413,0,0,1
249,miRNAs involved in DNA damage response WP1545,0.38683623675236073,2.2195169082125603,2.1079946984336297,['CDKN1A'],0.6365193726164413,0,0,1
250,Osteopontin Signaling WP1434,0.38683623675236073,2.2195169082125603,2.1079946984336297,['MAP3K14'],0.6365193726164413,0,0,1
251,Nonalcoholic fatty liver disease WP4396,0.38778243331729795,1.186127908015847,1.1236318195578678,"['SOCS3', 'XBP1', 'PIK3CD', 'FAS', 'IRS2', 'COX7A1', 'TNFRSF1A']",0.6365193726164413,0,0,7
252,Cardiac Hypertrophic Response WP2795,0.3903790612161485,1.362565445026178,1.2816795543508286,"['EGF', 'MAP3K14', 'TNFRSF1A']",0.638238782623227,0,0,3
253,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.4034179440733137,1.3321698662012798,1.209320055100411,"['ACTN2', 'ACTN1', 'DSC2']",0.6493981303316365,0,0,3
254,ATM Signaling Pathway WP2516,0.4059459492830171,1.479932894567041,1.3342116840560545,"['CDKN1A', 'GADD45A']",0.6493981303316365,0,0,2
255,Development of ureteric collection system WP5053,0.4059459492830171,1.479932894567041,1.3342116840560545,"['SMAD1', 'SPRY1']",0.6493981303316365,0,0,2
256,PDGFR-beta pathway WP3972,0.4059459492830171,1.479932894567041,1.3342116840560545,"['SHC1', 'FOS']",0.6493981303316365,0,0,2
257,Biomarkers for pyrimidine metabolism disorders WP4584,0.4161191903095923,1.9973913043478262,1.7512798277617607,['NT5C'],0.6493981303316365,0,0,1
258,BMP Signaling Pathway in Eyelid Development WP3927,0.4161191903095923,1.9973913043478262,1.7512798277617607,['SMAD1'],0.6493981303316365,0,0,1
259,Fatty acid transporters WP5061,0.4161191903095923,1.9973913043478262,1.7512798277617607,['FABP5'],0.6493981303316365,0,0,1
260,GPR40 Pathway WP3958,0.4161191903095923,1.9973913043478262,1.7512798277617607,['PLCE1'],0.6493981303316365,0,0,1
261,Imatinib and Chronic Myeloid Leukemia WP3640,0.4161191903095923,1.9973913043478262,1.7512798277617607,['GADD45A'],0.6493981303316365,0,0,1
262,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.4161191903095923,1.9973913043478262,1.7512798277617607,['MAP3K14'],0.6493981303316365,0,0,1
263,RalA downstream regulated genes WP2290,0.4161191903095923,1.9973913043478262,1.7512798277617607,['YBX3'],0.6493981303316365,0,0,1
264,Serotonin and anxiety WP3947,0.4161191903095923,1.9973913043478262,1.7512798277617607,['FOS'],0.6493981303316365,0,0,1
265,B Cell Receptor Signaling Pathway WP23,0.41972563194524815,1.2296933835395374,1.0675632769670331,"['BCL6', 'SHC1', 'INPP5D', 'ETS1']",0.6525545674016688,0,0,4
266,Neural Crest Cell Migration in Cancer WP4565,0.42276541826377884,1.4269537083125934,1.2285184156135396,"['PIK3CD', 'FOS']",0.6548095952055522,0,0,2
267,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.42883683914397475,1.1529352226720648,0.9761657655374185,"['SHC1', 'TRIP10', 'PIK3CD', 'IRS2', 'MAP3K6', 'MAP3K14']",0.6617257592783431,0,0,6
268,Ras signaling WP4223,0.4350883395687482,1.1281393503033053,0.9388445494252584,"['MRAS', 'SHC1', 'PLCE1', 'PIK3CD', 'PLA2G5', 'ETS1', 'FGFR3']",0.6676294334242073,0,0,7
269,Regulation of Actin Cytoskeleton WP51,0.4373932002784367,1.1418546365914788,0.9442255380917453,"['MRAS', 'EGF', 'ACTN1', 'TMSB4X', 'PIK3CD', 'FGFR3']",0.6676294334242073,0,0,6
270,Signaling of Hepatocyte Growth Factor Receptor WP313,0.4393354290019449,1.377628259041211,1.1330883356738437,"['HGF', 'FOS']",0.6676294334242073,0,0,2
271,PI3K-Akt signaling pathway WP4172,0.4410018232638678,1.0921238100754986,0.8941286100062413,"['EFNA1', 'CDKN1A', 'COL4A1', 'EGF', 'HGF', 'PIK3CD', 'LAMB1', 'OSMR', 'FGFR3', 'VEGFA']",0.6676294334242073,0,0,10
272,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.44200230651633,1.2485820244328099,1.0193925309688825,"['CDKN1A', 'PLCE1', 'MYH9']",0.6676294334242073,0,0,3
273,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.4440059824228952,1.8156521739130436,1.4741593067734193,['CD38'],0.6676294334242073,0,0,1
274,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.4440059824228952,1.8156521739130436,1.4741593067734193,['SYTL4'],0.6676294334242073,0,0,1
275,Pyrimidine metabolism WP4022,0.4519890296460469,1.1751336898395721,0.9331705726633792,"['NT5C', 'POLE4', 'ENPP3', 'POLR2I']",0.6771617462333503,0,0,4
276,IL-5 signaling pathway WP127,0.45564147538390326,1.3315911730545877,1.0466959325033274,"['SHC1', 'FOS']",0.6777050103182966,0,0,2
277,p38 MAPK Signaling Pathway WP400,0.45564147538390326,1.3315911730545877,1.0466959325033274,"['SHC1', 'HSPB1']",0.6777050103182966,0,0,2
278,Airway smooth muscle cell contraction WP4962,0.47056306943567816,1.6642028985507247,1.2545182180662746,['CD38'],0.6794701094799117,0,0,1
279,Canonical and non-canonical TGF-B signaling WP3874,0.47056306943567816,1.6642028985507247,1.2545182180662746,['LOXL2'],0.6794701094799117,0,0,1
280,miRNA targets in ECM and membrane receptors WP2911,0.47056306943567816,1.6642028985507247,1.2545182180662746,['COL4A1'],0.6794701094799117,0,0,1
281,Omega-3/Omega-6 FA synthesis WP4723,0.47056306943567816,1.6642028985507247,1.2545182180662746,['PLA2G5'],0.6794701094799117,0,0,1
282,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.47056306943567816,1.6642028985507247,1.2545182180662746,['BCL2L14'],0.6794701094799117,0,0,1
283,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.47056306943567816,1.6642028985507247,1.2545182180662746,['NQO1'],0.6794701094799117,0,0,1
284,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.47056306943567816,1.6642028985507247,1.2545182180662746,['F3'],0.6794701094799117,0,0,1
285,Fas ligand pathway and stress induction of heat shock proteins WP314,0.47167099832828824,1.2885242216477464,0.9682919018728249,"['HSPB1', 'FAS']",0.6794701094799117,0,0,2
286,Integrated Cancer Pathway WP1971,0.47167099832828824,1.2885242216477464,0.9682919018728249,"['BARD1', 'CDKN1A']",0.6794701094799117,0,0,2
287,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.47957992517420966,1.1748280464018068,0.8633161799214971,"['WIF1', 'WNT7B', 'WNT7A']",0.6863149260567287,0,0,3
288,Hepatitis B infection WP4666,0.47975412306878124,1.0894736842105264,0.8001983201852418,"['CDKN1A', 'IRF7', 'PIK3CD', 'FAS', 'TAB2', 'FOS']",0.6863149260567287,0,0,6
289,Nephrotic syndrome WP4758,0.48741323327111397,1.2481489547038327,0.8969734935518991,"['PLCE1', 'MYH9']",0.6948590038328684,0,0,2
290,ERK Pathway in Huntington's Disease WP3853,0.4958537494415931,1.5360535117056857,1.0775019938909645,['EGF'],0.7020334871819119,0,0,1
291,Nanomaterial induced apoptosis WP2507,0.4958537494415931,1.5360535117056857,1.0775019938909645,['FAS'],0.7020334871819119,0,0,1
292,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.502859068242698,1.2102206736353078,0.83196055103887,"['CXCL17', 'IRF7']",0.708640058622112,0,0,2
293,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.5039600416899971,1.1302973426849747,0.7745456314905919,"['RNF19A', 'HSPA1B', 'HSPA1A']",0.708640058622112,0,0,3
294,PDGF Pathway WP2526,0.5180009110088218,1.1745234679237548,0.7725760242248619,"['SHC1', 'FOS']",0.7212612282071842,0,0,2
295,Constitutive Androstane Receptor Pathway WP2875,0.5199383125668294,1.4262111801242237,0.9328064398055849,['CYP3A5'],0.7212612282071842,0,0,1
296,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.5199383125668294,1.4262111801242237,0.9328064398055849,['PLA2G5'],0.7212612282071842,0,0,1
297,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.5199383125668294,1.4262111801242237,0.9328064398055849,['LDLR'],0.7212612282071842,0,0,1
298,ErbB signaling pathway WP673,0.5246734234234988,1.064801864801865,0.6867751194093958,"['CDKN1A', 'SHC1', 'EGF', 'PIK3CD']",0.7253874176190654,0,0,4
299,Interleukin-11 Signaling Pathway WP2332,0.5328325653786377,1.1408661025385765,0.7182300192320605,"['SOCS3', 'ICAM1']",0.7309286390258672,0,0,2
300,Netrin-UNC5B signaling pathway WP4747,0.5328325653786377,1.1408661025385765,0.7182300192320605,"['INPP5D', 'ICAM1']",0.7309286390258672,0,0,2
301,Head and Neck Squamous Cell Carcinoma WP4674,0.5393882109617427,1.0694652206432311,0.6602019752114672,"['CDKN1A', 'FGFR3', 'VEGFA']",0.7309286390258672,0,0,3
302,Gastric Cancer Network 1 WP2361,0.5428741833541635,1.3310144927536232,0.8130870619194188,['GATD3A'],0.7309286390258672,0,0,1
303,Microglia Pathogen Phagocytosis Pathway WP3937,0.5428741833541635,1.3310144927536232,0.8130870619194188,['PIK3CD'],0.7309286390258672,0,0,1
304,"Relationship between inflammation, COX-2 and EGFR WP4483",0.5428741833541635,1.3310144927536232,0.8130870619194188,['PIK3CD'],0.7309286390258672,0,0,1
305,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.5428741833541635,1.3310144927536232,0.8130870619194188,['EGR1'],0.7309286390258672,0,0,1
306,Urea cycle and metabolism of amino groups WP497,0.5428741833541635,1.3310144927536232,0.8130870619194188,['ARG2'],0.7309286390258672,0,0,1
307,One-carbon metabolism and related pathways WP3940,0.5473491155423007,1.1090785907859078,0.668406667832296,"['BHMT', 'SOD2']",0.7345532104346185,0,0,2
308,Canonical and non-canonical Notch signaling WP3845,0.5647160568960381,1.2477173913043478,0.7129859292324874,['HES1'],0.7457147930806657,0,0,1
309,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.5647160568960381,1.2477173913043478,0.7129859292324874,['SHC1'],0.7457147930806657,0,0,1
310,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.5647160568960381,1.2477173913043478,0.7129859292324874,['MRAS'],0.7457147930806657,0,0,1
311,Kallmann's Syndrome WP5074,0.5647160568960381,1.2477173913043478,0.7129859292324874,['PRKCQ'],0.7457147930806657,0,0,1
312,Methionine De Novo and Salvage Pathway WP3580,0.5647160568960381,1.2477173913043478,0.7129859292324874,['BHMT'],0.7457147930806657,0,0,1
313,Cell cycle WP179,0.5736312812786398,0.9978146853146853,0.5545539272101807,"['CDKN1A', 'GADD45B', 'GADD45A', 'CDC7']",0.7491695764421437,0,0,4
314,Modulators of TCR signaling and T cell activation WP5072,0.5754230031604906,1.0505226480836236,0.5805711849122549,"['PRKCQ', 'MAP3K14']",0.7491695764421437,0,0,2
315,DNA IR-damage and cellular response via ATR WP4016,0.5842812004489621,0.9978184991273996,0.5362006249635067,"['BARD1', 'BCL6', 'PML']",0.7491695764421437,0,0,3
316,Ebstein-Barr virus LMP1 signaling WP262,0.5855160281902191,1.174219948849105,0.6285149907720093,['MAP3K14'],0.7491695764421437,0,0,1
317,Gastric Cancer Network 2 WP2363,0.5855160281902191,1.174219948849105,0.6285149907720093,['S100A6'],0.7491695764421437,0,0,1
318,Genes controlling nephrogenesis WP4823,0.5855160281902191,1.174219948849105,0.6285149907720093,['VEGFA'],0.7491695764421437,0,0,1
319,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.5855160281902191,1.174219948849105,0.6285149907720093,['ETV6'],0.7491695764421437,0,0,1
320,miRNA regulation of p53 pathway in prostate cancer WP3982,0.5855160281902191,1.174219948849105,0.6285149907720093,['TNFRSF10B'],0.7491695764421437,0,0,1
321,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.5855160281902191,1.174219948849105,0.6285149907720093,['IRF7'],0.7491695764421437,0,0,1
322,Urea cycle and associated pathways WP4595,0.5855160281902191,1.174219948849105,0.6285149907720093,['GLS2'],0.7491695764421437,0,0,1
323,PPAR signaling pathway WP3942,0.5889759779683968,1.023496828374877,0.5418083938274176,"['FABP5', 'ANGPTL4']",0.7511848521886415,0,0,2
324,G1 to S cell cycle control WP45,0.6022049427223958,0.997822299651568,0.5060530182258214,"['CDKN1A', 'GADD45A']",0.7511848521886415,0,0,2
325,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.6053237158413324,1.1088888888888888,0.5566532363882798,['IRAK2'],0.7511848521886415,0,0,1
326,Glycerolipids and Glycerophospholipids WP4722,0.6053237158413324,1.1088888888888888,0.5566532363882798,['PNPLA3'],0.7511848521886415,0,0,1
327,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.6053237158413324,1.1088888888888888,0.5566532363882798,['VEGFA'],0.7511848521886415,0,0,1
328,Hippo-Yap signaling pathway WP4537,0.6053237158413324,1.1088888888888888,0.5566532363882798,['NDRG1'],0.7511848521886415,0,0,1
329,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.6053237158413324,1.1088888888888888,0.5566532363882798,['NAMPT'],0.7511848521886415,0,0,1
330,PKC-gamma calcium signaling pathway in ataxia WP4760,0.6053237158413324,1.1088888888888888,0.5566532363882798,['GNA14'],0.7511848521886415,0,0,1
331,Vitamin D in inflammatory diseases WP4482,0.6053237158413324,1.1088888888888888,0.5566532363882798,['DUSP1'],0.7511848521886415,0,0,1
332,Zinc homeostasis WP3529,0.6053237158413324,1.1088888888888888,0.5566532363882798,['SLC39A14'],0.7511848521886415,0,0,1
333,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.6151099081179989,0.9734001869635421,0.4730280208390215,"['RNF125', 'IRF7']",0.7599383391026832,0,0,2
334,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.6160665176220781,0.9500540181168453,0.46020648761343613,"['EGF', 'PIK3CD', 'MAP3K14']",0.7599383391026832,0,0,3
335,DNA Mismatch Repair WP531,0.6241863791910888,1.0504347826086957,0.49507649990924946,['POLE4'],0.7608425687181318,0,0,1
336,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6241863791910888,1.0504347826086957,0.49507649990924946,['HGF'],0.7608425687181318,0,0,1
337,Sphingolipid Metabolism (general overview) WP4725,0.6241863791910888,1.0504347826086957,0.49507649990924946,['UGCG'],0.7608425687181318,0,0,1
338,Toll-like Receptor Signaling related to MyD88 WP3858,0.6241863791910888,1.0504347826086957,0.49507649990924946,['IRF7'],0.7608425687181318,0,0,1
339,Amino Acid metabolism WP3925,0.626289851780879,0.9351276178010471,0.43758548121072255,"['ARG2', 'BHMT', 'WARS']",0.7611546281230742,0,0,3
340,Glioblastoma signaling pathways WP2261,0.6363247327755762,0.9206604913411196,0.41618113167630466,"['CDKN1A', 'PIK3CD', 'PRKCQ']",0.7690854668660146,0,0,3
341,Estrogen signaling pathway WP712,0.6421490305871579,0.9978260869565218,0.4419719654747777,['FOS'],0.7690854668660146,0,0,1
342,SARS-CoV-2 mitochondrial interactions WP5038,0.6421490305871579,0.9978260869565218,0.4419719654747777,['IRF7'],0.7690854668660146,0,0,1
343,Sphingolipid Metabolism (integrated pathway) WP4726,0.6421490305871579,0.9978260869565218,0.4419719654747777,['UGCG'],0.7690854668660146,0,0,1
344,Trans-sulfuration and one-carbon metabolism WP2525,0.6421490305871579,0.9978260869565218,0.4419719654747777,['BHMT'],0.7690854668660146,0,0,1
345,"GPCRs, Other WP117",0.6592545419924285,0.9502277432712215,0.3959081741535177,['EDNRA'],0.7850082985574582,0,0,1
346,Physiological and pathological hypertrophy of the heart WP1528,0.6592545419924285,0.9502277432712215,0.3959081741535177,['FOS'],0.7850082985574582,0,0,1
347,Rett syndrome causing genes WP4312,0.6748228262973784,0.8672170883199515,0.34108090548434633,"['HAP1', 'SYNE2']",0.7997816768631931,0,0,2
348,MTHFR deficiency WP4288,0.6755437464766777,0.9069565217391304,0.35574223358582663,['BHMT'],0.7997816768631931,0,0,1
349,AGE/RAGE pathway WP2324,0.6858205824156254,0.8486915264289421,0.3200748663512477,"['LGALS3', 'SHC1']",0.8033464195584634,0,0,2
350,Regulatory circuits of the STAT3 signaling pathway WP4538,0.6858205824156254,0.8486915264289421,0.3200748663512477,"['SOCS3', 'OSMR']",0.8033464195584634,0,0,2
351,Glycerophospholipid Biosynthetic Pathway WP2533,0.6910555352201342,0.8674480151228734,0.3205524795536652,['PIK3CD'],0.8033464195584634,0,0,1
352,Nanoparticle-mediated activation of receptor signaling WP2643,0.6910555352201342,0.8674480151228734,0.3205524795536652,['PIK3CD'],0.8033464195584634,0,0,1
353,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.6910555352201342,0.8674480151228734,0.3205524795536652,['VEGFA'],0.8033464195584634,0,0,1
354,Sphingolipid pathway WP1422,0.6910555352201342,0.8674480151228734,0.3205524795536652,['UGCG'],0.8033464195584634,0,0,1
355,22q11.2 copy number variation syndrome WP4657,0.6925405963082449,0.8424157510508075,0.3094937916025403,"['ACTA2', 'AIFM3', 'HES1']",0.8033464195584634,0,0,3
356,Mesodermal commitment pathway WP2857,0.6941537023369247,0.8481624758220503,0.3096317793932136,"['SMAD1', 'FZD4', 'HMGA2', 'TBX6']",0.8033464195584634,0,0,4
357,Wnt signaling WP428,0.7012443143004927,0.8306428155904596,0.2947942465711377,"['WIF1', 'WNT7B', 'WNT7A']",0.8092791526381036,0,0,3
358,BDNF-TrkB Signaling WP3676,0.7058269494273941,0.831231884057971,0.28958887425386176,['SHC1'],0.8122924669387888,0,0,1
359,G Protein Signaling Pathways WP35,0.7097593587055386,0.8191924263071075,0.28084316427202244,"['GNA14', 'PRKCQ', 'PDE8B']",0.8145427737790583,0,0,3
360,Proximal tubule transport WP4917,0.7198932685184511,0.7979130434782609,0.26223596980884323,['SLC3A1'],0.823877851748894,0,0,1
361,3q29 copy number variation syndrome WP4906,0.7267858292567757,0.7818542050966728,0.2495080035835605,"['TFRC', 'PIGM']",0.8254499850244258,0,0,2
362,AMP-activated protein kinase (AMPK) signaling WP1403,0.7267858292567757,0.7818542050966728,0.2495080035835605,"['CDKN1A', 'PIK3CD']",0.8254499850244258,0,0,2
363,Base Excision Repair WP4752,0.7332880934925725,0.7671571906354515,0.23798491137709651,['POLE4'],0.8254499850244258,0,0,1
364,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.7332880934925725,0.7671571906354515,0.23798491137709651,['FOS'],0.8254499850244258,0,0,1
365,Intraflagellar transport proteins binding to dynein WP4532,0.7332880934925725,0.7671571906354515,0.23798491137709651,['IFT27'],0.8254499850244258,0,0,1
366,Lipid Metabolism Pathway WP3965,0.7332880934925725,0.7671571906354515,0.23798491137709651,['HILPDA'],0.8254499850244258,0,0,1
367,Ectoderm Differentiation WP2858,0.7511463834716748,0.7810914575620458,0.22351301369160462,"['CLDN11', 'FZD4', 'BOC', 'TNFRSF11B']",0.8432488010635695,0,0,4
368,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.7544649093341534,0.7382242870047748,0.20799211672602513,"['EGR1', 'FOS']",0.8446726702328022,0,0,2
369,miRNA regulation of prostate cancer signaling pathways WP3981,0.758189748298807,0.7122360248447205,0.1971623139064646,['CDKN1A'],0.846542483195416,0,0,1
370,MECP2 and Associated Rett Syndrome WP3584,0.7631389829529155,0.7247386759581882,0.19590781564140905,"['CEBPD', 'BCL6']",0.8497655702070301,0,0,2
371,CAMKK2  Pathway WP4874,0.7697560873395392,0.687616191904048,0.1799364942852353,['ICAM1'],0.8499385101419343,0,0,1
372,DNA Replication WP466,0.7697560873395392,0.687616191904048,0.1799364942852353,['CDC7'],0.8499385101419343,0,0,1
373,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.7697560873395392,0.687616191904048,0.1799364942852353,['TNFRSF1A'],0.8499385101419343,0,0,1
374,Proteasome Degradation WP183,0.7715461232841831,0.7117346938775511,0.1845946739578054,"['NEDD4', 'PSMB9']",0.8499385101419343,0,0,2
375,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.780770092049109,0.6646376811594202,0.16448091029846523,['SHC1'],0.8532553791093711,0,0,1
376,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.780770092049109,0.6646376811594202,0.16448091029846523,['MAP3K14'],0.8532553791093711,0,0,1
377,Vitamin D-sensitive calcium signaling in depression WP4698,0.780770092049109,0.6646376811594202,0.16448091029846523,['CALB1'],0.8532553791093711,0,0,1
378,Amyotrophic lateral sclerosis (ALS) WP2447,0.7912580945917138,0.6431416549789621,0.15057944734329684,['TNFRSF1A'],0.8601539181313618,0,0,1
379,NO/cGMP/PKG mediated Neuroprotection WP4008,0.7912580945917138,0.6431416549789621,0.15057944734329684,['ACTN2'],0.8601539181313618,0,0,1
380,G13 Signaling Pathway WP524,0.8107552153886325,0.6040579710144928,0.12672477870327303,['PIK3CD'],0.8767221751709097,0,0,1
381,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.8107552153886325,0.6040579710144928,0.12672477870327303,['ACTA2'],0.8767221751709097,0,0,1
382,Alzheimer's disease WP2059,0.8167046994081255,0.6425199505451276,0.1300959582515096,"['FAS', 'TNFRSF1A']",0.8808438119270882,0,0,2
383,Hedgehog Signaling Pathway WP4249,0.8284340938063581,0.5694409937888198,0.10717904160650575,['BOC'],0.8903963179595085,0,0,1
384,Leptin signaling pathway WP2034,0.8298839468360467,0.6223323170731707,0.11604594064621875,"['SOCS3', 'SHC1']",0.8903963179595085,0,0,2
385,Pathways Regulating Hippo Signaling WP4540,0.8361483680403495,0.6127043688019298,0.1096429614810575,"['PRKCQ', 'FGFR3']",0.894787344500322,0,0,2
386,ATM Signaling Network in Development and Disease  WP3878,0.8519091981019135,0.5243478260869565,0.08404002234482325,['HSPB1'],0.9018671134887587,0,0,1
387,Phosphodiesterases in neuronal function WP4222,0.8519091981019135,0.5243478260869565,0.08404002234482325,['PDE8B'],0.9018671134887587,0,0,1
388,Chemokine signaling pathway WP3929,0.8529877967078036,0.6282722513089005,0.0999015945010956,"['GRK5', 'SHC1', 'PIK3CD']",0.9018671134887587,0,0,3
389,Hippo-Merlin Signaling Dysregulation WP4541,0.8537091608267375,0.5855195736831318,0.09260853022787988,"['FGFR3', 'CD44']",0.9018671134887587,0,0,2
390,Pathways in clear cell renal cell carcinoma WP4018,0.8537091608267375,0.5855195736831318,0.09260853022787988,"['ENPP3', 'VEGFA']",0.9018671134887587,0,0,2
391,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.8589985700843062,0.5108584169453735,0.07764436012330868,['PDCD4'],0.9030092058623753,0,0,1
392,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.861866145111473,0.6465404514185003,0.09611166765758532,"['EGR1', 'SHC1', 'IRS2', 'FOS']",0.9030092058623753,0,0,4
393,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.8657491172709666,0.4980434782608696,0.07179800525650705,['SYNE2'],0.9030092058623753,0,0,1
394,Eukaryotic Transcription Initiation WP405,0.8657491172709666,0.4980434782608696,0.07179800525650705,['POLR2I'],0.9030092058623753,0,0,1
395,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.8657491172709666,0.4980434782608696,0.07179800525650705,['CP'],0.9030092058623753,0,0,1
396,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.8721770063617837,0.48585365853658535,0.0664467488676702,['XBP1'],0.9051307975341434,0,0,1
397,Nucleotide Excision Repair WP4753,0.8721770063617837,0.48585365853658535,0.0664467488676702,['POLE4'],0.9051307975341434,0,0,1
398,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.8782976339466869,0.47424430641821946,0.06154256601412137,['PIK3CD'],0.905575965115745,0,0,1
399,Synaptic Vesicle Pathway WP2267,0.8782976339466869,0.47424430641821946,0.06154256601412137,['SLC22A3'],0.905575965115745,0,0,1
400,Integrin-mediated Cell Adhesion WP185,0.8791999661317913,0.5451768412008974,0.07018765540741097,"['CAV3', 'SHC1']",0.905575965115745,0,0,2
401,Androgen receptor signaling pathway WP138,0.8881978874451563,0.5305458768873403,0.06290189828891556,"['CDKN1A', 'LIMK2']",0.9125624180234523,0,0,2
402,Pathways affected in adenoid cystic carcinoma WP3651,0.9255095310387802,0.38270903010033447,0.029625830849151442,['ERBIN'],0.9485321561889986,0,0,1
403,Ciliopathies WP4803,0.9382813604882199,0.5325010559909888,0.03392320186622963,"['DNAH11', 'SPAG1', 'IFT27', 'PKD1L1']",0.9592355347919271,0,0,4
404,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9471852083104775,0.33709653647752397,0.0182910708448065,['LDLR'],0.9659413510492988,0,0,1
405,16p11.2 proximal deletion syndrome WP4949,0.9521293254691302,0.3259871703492516,0.01599110744062088,['TBX6'],0.9685301006805203,0,0,1
406,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.9544252933890562,0.3207012622720898,0.014959401150519165,['PRKCQ'],0.9685301006805203,0,0,1
407,7q11.23 copy number variation syndrome WP4932,0.9821011495307455,0.24506709608158883,0.004426150042968272,['FAS'],0.9941662742178553,0,0,1
408,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.9853007728232737,0.23345268542199488,0.00345704470877846,['COX7A1'],0.994960584321541,0,0,1
409,Genes related to primary cilium development (based on CRISPR) WP4536,0.9918614179598668,0.20435679067682652,0.0016699793940395528,['IFT27'],0.9964462524004141,0,0,1
410,DNA Repair Pathways Full Network WP4946,0.9933178145378457,0.19619457597933707,0.0013154083556719248,['POLE4'],0.9964462524004141,0,0,1
411,Fragile X Syndrome  WP4549,0.9959191562225247,0.1783627105366236,0.0007293595729211249,['SHC1'],0.9964462524004141,0,0,1
412,Ciliary landscape WP4352,0.9964462524004141,0.3033964290508793,0.0010801146977357792,"['CDH23', 'IFT27', 'MAPRE2']",0.9964462524004141,0,0,3
